Benign prostatic hyperplasia (BPH) — an enlarged prostate gland — affects more than 50% of South African men over the age of 50, and up to 80% by age 80. It is the most common urological condition in older men, causing lower urinary tract symptoms (LUTS) that significantly impact quality of life. From a medical aid perspective, BPH is not a PMB condition in routine cases, but it can transition to PMB-covered surgery if it progresses to significant urinary obstruction. Understanding where that line is matters.
What Is BPH?
The prostate gland encircles the urethra just below the bladder. As men age, the prostate tends to enlarge — compressing the urethra and progressively impairing urine flow. This is BPH: a benign (non-cancerous) process, distinct from prostate cancer (which also causes urinary symptoms, but requires entirely different management).
Common symptoms (LUTS): - Frequent urination, especially at night (nocturia) - Urgency — sudden, strong need to urinate - Weak or interrupted urine stream - Incomplete bladder emptying - Straining to urinate - Post-void dribbling
Complications of untreated BPH: - Acute urinary retention (AUR) — sudden inability to urinate — a medical emergency - Recurrent urinary tract infections - Bladder stones - Obstructive nephropathy (kidney damage from chronic urinary obstruction) — a serious complication that may qualify for PMB
Is BPH a PMB or CDL Condition?
BPH is not on the CDL. There is no BPH entry in the 27 CDL conditions.
BPH's PMB status is nuanced:
- Routine BPH management (medication, monitoring) — NOT a standard PMB Diagnosis and Treatment Pair. All costs from day-to-day benefit.
- Obstructive uropathy — chronic urinary obstruction causing kidney impairment — IS a PMB condition. If BPH has caused significant obstruction and renal compromise, surgical intervention (TURP or equivalent) may qualify as PMB-covered.
- Acute urinary retention — the acute event (emergency catheterisation, emergency TURP) — is covered as an acute emergency under relevant PMB DTPs.
- Bladder cancer / prostate cancer — if suspected, diagnostic workup and treatment are under cancer PMB DTPs.
Practical implication: Routine medication and monitoring are day-to-day costs. If BPH progresses to the point of requiring surgery due to urinary obstruction with renal compromise, this shifts toward PMB coverage. Document the clinical pathway with your urologist.
How Does Medical Aid Cover BPH?
| Service | Typical cover | Notes |
|---|---|---|
| GP consultation | Day-to-day | Annual PSA test should be co-discussed |
| Urologist consultation | Day-to-day | Shortfall likely; R1,500–R3,000/visit |
| PSA blood test (prostate-specific antigen) | Pathology benefit | R300–R600; important to track and detect prostate cancer |
| IPSS questionnaire assessment (symptom scoring) | Part of GP consultation | |
| Urine flow studies (uroflowmetry) | Day-to-day / outpatient procedure | |
| Ultrasound (bladder, prostate — transrectal or transabdominal) | Radiology benefit | R800–R2,000 |
| Alpha-blockers (tamsulosin, alfuzosin, silodosin) | Acute/chronic benefit | Generic tamsulosin: R400–R800/month; most commonly used |
| 5-alpha reductase inhibitors (finasteride, dutasteride) | Acute/chronic benefit | Generic finasteride: R200–R500/month; dual therapy common |
| Combination therapy (alpha-blocker + 5-ARI) | Both benefits apply | Significantly better symptom control for moderate-severe BPH |
| PDE5 inhibitor (tadalafil — for LUTS/BPH + erectile dysfunction) | Day-to-day — check formulary | Low-dose daily tadalafil; increasingly used; check formulary status |
| TURP (surgical — transurethral resection of prostate) | Hospital/surgical benefit (day-to-day or PMB depending on indication) | R40,000–R80,000 total; covered in-hospital under surgical benefit |
| Laser prostatectomy (HoLEP, GreenLight) | Hospital/surgical benefit | More expensive equipment; confirm facility capability |
| Prostate artery embolisation (PAE) | Day-to-day — may require motivation | Newer technique; not universally covered |
Day-to-Day Costs: What to Budget For
| Scenario | Estimated annual cost |
|---|---|
| Mild LUTS, GP-managed, watchful waiting + PSA monitoring | R5,000 – R12,000 |
| Moderate BPH, urologist + alpha-blocker + monitoring | R12,000 – R25,000 |
| Severe BPH requiring TURP (surgical — once-off) | R40,000 – R80,000 for surgery + recovery |
Medical management with generic tamsulosin (R400–R800/month) and finasteride (R200–R500/month) totals R600–R1,300/month in medication alone — about R7,000–R16,000/year in medication plus periodic urology visits.
TURP cost breakdown: The hospital stay, surgeon, anaesthetist, and facility fees together total R40,000–R80,000 in the private sector. Medical aid funds this from hospital/surgical benefits; gap cover covers specialist shortfalls. Patient co-payments depend on DSP network and plan benefit structure.
Gap Cover Relevance
Gap cover is highly relevant for TURP and other BPH surgeries. The urologist performing the TURP will typically bill 2–3 times medical aid tariff, creating a shortfall of R10,000–R25,000 or more. Gap cover's OPL covers this shortfall.
Key Questions to Ask Your Scheme
- If my BPH has caused obstructive uropathy (renal impairment), does TURP become a PMB? Ask your urologist to document the renal impairment clearly and refer to the obstructive uropathy PMB DTP in the pre-authorisation request.
- Is tamsulosin / finasteride on my formulary? Confirm generic is available and covered under your chronic or acute medication benefit.
- What does my surgical benefit cover for a TURP? Confirm the facility, surgeon, anaesthetist, and hospital stay benefit structure before scheduling.
- Is my urologist in-network (DSP)? Confirm separately from the hospital — a private urologist may not be a scheme DSP even at a DSP hospital.
- What is my specialist consultation sub-limit? BPH requires periodic urology reviews; quarterly visits on a limited sub-limit add up.
Talk to Eldon
BPH management benefits from a plan with solid medication and outpatient benefits. If surgery is anticipated, understanding your hospital and surgical gap cover is critical. The Check sets the plans side by side, and Eldon advises from there.
See which plans pay for BPH management →